Literature DB >> 18336869

Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis.

Carlos Gonzalez-Juanatey1, Javier Llorca, Javier Martin, Miguel A Gonzalez-Gay.   

Abstract

OBJECTIVE: To establish whether carotid intima-media wall thickness (IMT) may be a good predictor for the development of cardiovascular (CV) events in patients with rheumatoid arthritis (RA).
METHODS: A series of 47 RA patients who at the time of recruitment did not have traditional CV risk factors or CV disease were assessed by carotid ultrasonography. Carotid IMT and carotid plaques were measured in the right common carotid artery. Then, a prospective assessment of the CV outcome was performed over a 5-year period. Logistic regression models and receiver operating characteristic curves were performed to evaluate the ability of different variables to predict CV events.
RESULTS: Carotid IMT was greater in RA patients who over the extended follow-up experienced CV events (1.01 +/- 0.16 mm) compared with the remaining RA patients who did not have CV complications (0.74 +/- 0.12 mm) (P < 0.001). Also, carotid IMT categorized in quartiles was strongly associated with CV events. In this regard, none of the patients with carotid IMT less than 0.77 mm had CV events. However, 6 of the 10 patients with carotid IMT greater than 0.91 mm experienced CV events (P value for the trend <0.001). Carotid IMT yielded a high predictive power for the development of CV events over the 5-year follow-up period. The area under the receiver operating characteristic curve was 0.93 for a model that only included carotid IMT and 0.90 for carotid plaque.
CONCLUSIONS: The results from the present study support the use of carotid ultrasonography as a predictor of CV events in RA.

Entities:  

Mesh:

Year:  2008        PMID: 18336869     DOI: 10.1016/j.semarthrit.2008.01.012

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  89 in total

1.  Differential Association of Psychosocial Comorbidities With Subclinical Atherosclerosis in Rheumatoid Arthritis.

Authors:  Ying L Liu; Moyses Szklo; Karina W Davidson; Joan M Bathon; Jon T Giles
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-10       Impact factor: 4.794

2.  Relationship between pulse wave velocity and serum YKL-40 level in patients with early rheumatoid arthritis.

Authors:  Aysegul Kucukali Turkyilmaz; Gul Devrimsel; Aynur Kirbas; Yuksel Cicek; Murat Karkucak; Erhan Capkin; Ferhat Gokmen
Journal:  Rheumatol Int       Date:  2013-06-25       Impact factor: 2.631

Review 3.  Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review.

Authors:  Emilio Martin-Mola; Alejandro Balsa; Rosario García-Vicuna; Juan Gómez-Reino; Miguel Angel González-Gay; Raimon Sanmartí; Estíbaliz Loza
Journal:  Rheumatol Int       Date:  2016-06-06       Impact factor: 2.631

4.  Lack of association between TLR4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis.

Authors:  Mercedes García-Bermúdez; Raquel López-Mejías; Carlos González-Juanatey; Santos Castañeda; José A Miranda-Filloy; Ricardo Blanco; Benjamín Fernández-Gutiérrez; Alejandro Balsa; Isidoro González-Alvaro; Carmen Gómez-Vaquero; Javier Llorca; Javier Martín; Miguel A González-Gay
Journal:  DNA Cell Biol       Date:  2012-02-23       Impact factor: 3.311

5.  Assessment of cardiovascular risk in rheumatoid arthritis: impact of the new EULAR recommendations on the score cardiovascular risk index.

Authors:  Carmen Gómez-Vaquero; Montserrat Robustillo; Javier Narváez; Jesús Rodríguez-Moreno; Carlos González-Juanatey; Javier Llorca; Joan Miquel Nolla; Miguel Angel González-Gay
Journal:  Clin Rheumatol       Date:  2011-05-13       Impact factor: 2.980

6.  Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis.

Authors:  Inmaculada del Rincón; Joseph F Polak; Daniel H O'Leary; Daniel F Battafarano; John M Erikson; Jose F Restrepo; Emily Molina; Agustín Escalante
Journal:  Ann Rheum Dis       Date:  2014-05-20       Impact factor: 19.103

7.  Role of carotid ultrasonography in the evaluation of cardiovascular risk in patients with rheumatoid arthritis.

Authors:  Miguel A Gonzalez-Gay; Carlos Gonzalez-Juanatey; Jose A Miranda-Filloy; Javier Martin; Javier Llorca
Journal:  Arthritis Res Ther       Date:  2010-12-16       Impact factor: 5.156

8.  Rheumatoid arthritis is sufficient to cause atheromatosis but not arterial stiffness or hypertrophy in the absence of classical cardiovascular risk factors.

Authors:  Aikaterini Arida; Evi Zampeli; George Konstantonis; Kalliope Fragiadaki; George D Kitas; Athanasios D Protogerou; Petros P Sfikakis
Journal:  Clin Rheumatol       Date:  2015-03-11       Impact factor: 2.980

Review 9.  Cardiovascular comorbidity in rheumatic diseases.

Authors:  Michael T Nurmohamed; Maaike Heslinga; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2015-08-18       Impact factor: 20.543

10.  Relationship between inflammatory markers, oxidant-antioxidant status and intima-media thickness in prepubertal children with juvenile idiopathic arthritis.

Authors:  L Breda; D Di Marzio; C Giannini; S Gaspari; M Nozzi; A Scarinci; F Chiarelli; A Mohn
Journal:  Clin Res Cardiol       Date:  2012-08-11       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.